≡ SectionsRSS
Today’s Briefing

The Brand News

Vol. I·Section: Health & Biotech (6)·Oct 27, 2026
A Fifth Measles Death, and a Count That Does Not Add Up
Health & Biotech

A Fifth Measles Death, and a Count That Does Not Add Up

A preventable outbreak keeps killing unvaccinated people while the CDC's official toll appears to lag the reality on the ground

By the editors·
An Ebola Outbreak The World Is Already Routing Around
Health & Biotech

An Ebola Outbreak The World Is Already Routing Around

600 cases, a nine-month vaccine timeline, burned treatment tents, and a US policy of sending exposed citizens elsewhere

By the editors·
ACA Enrollment Set to Fall by Five Million
Health & Biotech

ACA Enrollment Set to Fall by Five Million

Enhanced subsidies expired, and KFF projects the marketplace will shed roughly a fifth of its enrollees

By the editors·

More From The Editors

Ebola Returns to Congo Without a Vaccine That Works
Health & Biotech

Ebola Returns to Congo Without a Vaccine That Works

The WHO's highest alert lands on an outbreak strain with no approved countermeasure, exposing the gap between past Ebola wins and present readiness

By the editors·
Vaccines, the Gut, and the Brain: Two Studies Reopen Old Questions
Health & Biotech

Vaccines, the Gut, and the Brain: Two Studies Reopen Old Questions

Routine immunizations linked to lower dementia risk and fecal transplants showing durable effects in autism point to immunology rethinking itself

By the editors·
Ebola Returns With a Rare Strain and a Reporting Gap
Health & Biotech

Ebola Returns With a Rare Strain and a Reporting Gap

An outbreak across Congo and Uganda has killed at least 65, and the U.S. CDC says it learned late

By the editors·

In the wires

Raw stories we’re tracking. Some will become posts above; many won’t. Listed here so you can see the source feed.